收益表 (TTM)
尤利塞生物医学公司 损益表显示一段时间内收入和支出的变化。损益表数据包括销售和收入、毛利、研发、销售、一般和管理费用、经营收入、所得税费用、利息费用、营业外收入、每股收益和已发行股票。
除每股单位外,所有数字都是 1,000,000。
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
收入 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
改变 (%) | 7.97 | 7.39 | -30.03 | -42.91 | -14.65 | -17.17 | -15.09 | -17.77 | -17.17 | -20.72 | -13.59 | -15.72 | 267.88 | 72.82 | 41.22 | 29.19 | |
收入百分比 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
销售成本 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
改变 (%) | 2.60 | 2.54 | 36.69 | 26.84 | 34.73 | 25.78 | 5.85 | 5.53 | 1.24 | 1.22 | 26.28 | 20.81 | 7.76 | 7.20 | -0.58 | -0.59 | |
收入百分比 | 49.43 | 46.97 | 44.85 | 87.60 | 194.64 | 307.26 | 466.56 | 581.59 | 746.35 | 912.18 | 1,164.71 | 1,701.99 | 2,439.68 | 714.64 | 443.30 | 312.08 | 240.15 |
毛营业利润 | 0 | 0 | 0 | 0 | -0 | -0 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -1 | -1 | -1 | -1 |
改变 (%) | 13.23 | 11.68 | -84.27 | -535.85 | 86.91 | 46.50 | 11.56 | 10.36 | 4.09 | 3.93 | 30.02 | 23.09 | -3.36 | -3.47 | -12.76 | -14.63 | |
收入百分比 | 50.57 | 53.03 | 55.15 | 12.40 | -94.64 | -207.26 | -366.56 | -481.59 | -646.35 | -812.17 | -1,064.71 | -1,601.99 | -2,339.68 | -614.64 | -343.30 | -212.08 | -140.15 |
销售、一般及行政费用 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
改变 (%) | -19.71 | -24.54 | 42.73 | 29.94 | 39.19 | 28.16 | 10.22 | 9.28 | 8.87 | 8.14 | 10.38 | 9.40 | 79.62 | 44.33 | 15.48 | 13.41 | |
收入百分比 | 29.33 | 21.81 | 15.33 | 31.27 | 71.17 | 116.07 | 179.57 | 233.10 | 309.77 | 407.13 | 555.39 | 709.42 | 920.90 | 449.64 | 375.52 | 307.09 | 269.58 |
研发 | |||||||||||||||||
改变 (%) | |||||||||||||||||
收入百分比 | |||||||||||||||||
运营支出 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 5 | 6 | 8 | 7 | 7 |
改变 (%) | 18.02 | 15.27 | 35.21 | 26.04 | 34.53 | 25.67 | 10.29 | -5.87 | 2.89 | 2.81 | 92.11 | 55.90 | 26.61 | 21.02 | -3.79 | -3.94 | |
收入百分比 | 62.97 | 68.82 | 73.88 | 142.75 | 315.18 | 496.81 | 753.72 | 979.02 | 1,120.66 | 1,391.97 | 1,805.14 | 4,012.99 | 7,422.92 | 2,554.76 | 1,789.04 | 1,218.84 | 906.30 |
营业收入 | 0 | 0 | 0 | -0 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -3 | -5 | -6 | -7 | -7 | -6 |
改变 (%) | -9.11 | -10.02 | -214.52 | 187.32 | 57.39 | 36.46 | 14.18 | -4.52 | 4.85 | 4.63 | 98.31 | 57.73 | 23.32 | 18.91 | -6.45 | -6.90 | |
收入百分比 | 37.03 | 31.18 | 26.12 | -42.75 | -215.18 | -396.81 | -653.72 | -879.02 | -1,020.66 | -1,291.97 | -1,705.14 | -3,912.99 | -7,322.92 | -2,454.76 | -1,689.04 | -1,118.84 | -806.30 |
利息花费 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
改变 (%) | 175.86 | 62.50 | 28.46 | 23.35 | -16.99 | -20.47 | 10.29 | 9.33 | 27.44 | 21.53 | -22.44 | -29.44 | 5,372.66 | 98.19 | 30.40 | 23.31 | |
收入百分比 | -0.00 | -0.01 | -0.02 | -0.03 | -0.07 | -0.07 | -0.07 | -0.09 | -0.12 | -0.18 | -0.28 | -0.25 | -0.21 | -3.12 | -3.58 | -3.31 | -3.16 |
净利 | 0 | 0 | 0 | -0 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -3 | -5 | -6 | -7 | -6 | -6 |
改变 (%) | -9.23 | -10.17 | -216.83 | 185.59 | 36.71 | 26.86 | 12.46 | 11.08 | 14.07 | 12.33 | 93.13 | 48.22 | 22.62 | 18.44 | -7.37 | -7.96 | |
收入百分比 | 36.64 | 30.80 | 25.77 | -43.02 | -215.23 | -344.77 | -527.99 | -699.30 | -944.65 | -1,300.86 | -1,843.32 | -4,119.66 | -7,245.12 | -2,414.82 | -1,655.06 | -1,085.61 | -773.49 |
Source: Capital IQ